Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

August 27, 2018

Conditions
Breast Cancer
Interventions
DIETARY_SUPPLEMENT

Omega-3 Fatty Acids

Amber 4020 Ethyl Ester (EE) 1000 mg omega-3 capsule contains 420 mg of EPA and 210 mg of DHA both as the ethyl esters (380 mg EPA and 190 mg DHA)

OTHER

Placebo Capsule

OTHER

Diet and Exercise

Increasing physical activity required over 6 month period to be tracked by a Fitbit. Diet based on caloric intake and eating approved foods.

Trial Locations (1)

66205

University of Kansas Medical Center, Breast Cancer Prevention Center, Kansas City

All Listed Sponsors
collaborator

DSM Nutritional Products, Inc.

INDUSTRY

lead

Carol Fabian, MD

OTHER

NCT02101970 - Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women | Biotech Hunter | Biotech Hunter